June 26th&27th 2018, BIOASTER invited to join a Brazilian public-private initiative network. The University of Sao Paulo (USP), private organizations led by the Brazilian health company Eurofarma, public funders like...
BIOASTER is proud to be “co-author” of this paper in Nature Communications “A modular transcriptional signature identifies phenotypic heterogeneity of human tuberculosis infection” Full-text access by clicking here.
BIOASTER participates in the Pasteur course Christophe Vedrine (Biological Microsystems and Advanced Optics engineering unit) and Fabrice Porcheray (Immunomonitoring Unit) had the opportunity to give a presentation as part of...
New publication in Vaccine May 2018, based on an innovative platform on nanoparticles. The Protein & Expression system engineering Unit has developed a new nanoparticle carrier system that enables simultaneous...
BIOASTER announces today, the initiation of a collaborative project aiming at improving the safety and immunogenicity of adjuvants included in the composition of new candidate vaccines. MOSAIC (MOlecular Signatures of...
This morning, BIOASTER welcomed the Singapore Ambassador to France, Mr Zainal Arif MANTAHA, for a very interesting meeting. Dr. Cyril Guyard leads the visit of our HQ.
Nathalie Garçon, CEO / CSO will introduce BIOASTER at International Society of Vaccines, Plenary Session ” Public Private Partnerships” Oct sat 7thPartnerships” Oct sat 7th
The European Commission announces the start of the TRANSVAC2 project, coordinated by the European Vaccines Initiative (EVI) in the context of the Horizon 2020 Program. This project will offer services...
BIOASTER at JOBIM BIOASTER was at the edition 2016 of the Open Days in Biology, IT and Mathematical (JOBIM). Our bioIT specialists team was there during the 3 days of...
Today, BIOASTER had the honor to present the Biodistrict and the model for innovation of the TRI to a delegation of the Brookings Institution invited by Mr Gérard COLLOMB. Mister...
By continuing browsing this website, you accept the use of cookies or other tracers for statistics of visits to optimize the functionality of the site, and or privacy policy. AcceptRejectRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
